DE69811312T2 - Arylacetamid Derivate, deren Salze und sie enthaltende Pharmazeutika - Google Patents

Arylacetamid Derivate, deren Salze und sie enthaltende Pharmazeutika

Info

Publication number
DE69811312T2
DE69811312T2 DE69811312T DE69811312T DE69811312T2 DE 69811312 T2 DE69811312 T2 DE 69811312T2 DE 69811312 T DE69811312 T DE 69811312T DE 69811312 T DE69811312 T DE 69811312T DE 69811312 T2 DE69811312 T2 DE 69811312T2
Authority
DE
Germany
Prior art keywords
salts
pharmaceuticals containing
arylacetamide
derivatives
arylacetamide derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69811312T
Other languages
English (en)
Other versions
DE69811312D1 (de
Inventor
Terumitsu Kaihoh
Tomomi Okada
Yoshinori Takahashi
Hiroyuki Mizuno
Haruyoshi Honda
Susumo Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Application granted granted Critical
Publication of DE69811312D1 publication Critical patent/DE69811312D1/de
Publication of DE69811312T2 publication Critical patent/DE69811312T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/94—Oxygen atom, e.g. piperidine N-oxide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
DE69811312T 1997-10-31 1998-10-28 Arylacetamid Derivate, deren Salze und sie enthaltende Pharmazeutika Expired - Fee Related DE69811312T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30035297 1997-10-31

Publications (2)

Publication Number Publication Date
DE69811312D1 DE69811312D1 (de) 2003-03-20
DE69811312T2 true DE69811312T2 (de) 2003-10-16

Family

ID=17883758

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69811312T Expired - Fee Related DE69811312T2 (de) 1997-10-31 1998-10-28 Arylacetamid Derivate, deren Salze und sie enthaltende Pharmazeutika

Country Status (6)

Country Link
US (1) US6060485A (de)
EP (1) EP0913393B1 (de)
KR (1) KR19990037220A (de)
CA (1) CA2253156A1 (de)
DE (1) DE69811312T2 (de)
TW (1) TW442470B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0100819A3 (en) * 1998-10-16 2002-12-28 Daiichi Asubio Pharma Co Ltd Aminophenoxyacetic acid derivatives as neuroprotectants and pharmaceutical compositions containing them
GB9917406D0 (en) 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
US6777576B2 (en) 2000-11-07 2004-08-17 Sumika Fine Chemicals Co., Ltd. Production method of 2-cyclohexyl-2-hydroxy-2-phenylacetic acid intermediate therefor and production method thereof
WO2003087029A1 (fr) * 2002-04-18 2003-10-23 Sumika Fine Chemicals Co., Ltd. Procede de production de compose d'acide $g(a)-hydroxycarboxylique
RU2016152499A (ru) * 2014-05-30 2018-07-04 Драг Дискавери Ресеч Сентэ Новые соединения в качестве противотуберкулезных препаратов

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2816895A (en) * 1954-11-30 1957-12-17 Hoechst Ag Basic benzilic esters and a process of preparing them
FR2465723A1 (fr) * 1979-05-30 1981-03-27 Italiana Schoum Spa Nouvelles diphenylpropylamino-pyridines utilisables comme medicaments
US4584303A (en) * 1984-04-09 1986-04-22 The Boc Group, Inc. N-aryl-N-(4-piperidinyl)amides and pharmaceutical compositions and method employing such compounds
US5066680A (en) * 1989-02-14 1991-11-19 Fujisawa Pharmaceutical Co., Ltd. Novel substituted-acetamide compound and a process for the preparation thereof
GB9202443D0 (en) * 1992-02-05 1992-03-18 Fujisawa Pharmaceutical Co A novel substituted-acetamide compound and a process for the preparation thereof
JPH08291141A (ja) * 1995-04-21 1996-11-05 Kotobuki Seiyaku Kk ジフェニル酢酸誘導体及びその製造法
AU700837B2 (en) * 1995-04-28 1999-01-14 Banyu Pharmaceutical Co., Ltd. 1,4-di-substituted piperidine derivatives
CA2179574A1 (en) * 1995-06-26 1996-12-27 Tomomi Okada Substituted piperidine derivative and medicine comprising the same
JP3965442B2 (ja) * 1995-06-26 2007-08-29 久光製薬株式会社 置換ピペリジン誘導体及びこれを含有する医薬
AU7145996A (en) * 1995-10-13 1997-04-30 Banyu Pharmaceutical Co., Ltd. Substituted heteroaromatic derivatives

Also Published As

Publication number Publication date
US6060485A (en) 2000-05-09
EP0913393A2 (de) 1999-05-06
EP0913393A3 (de) 1999-05-26
CA2253156A1 (en) 1999-04-30
TW442470B (en) 2001-06-23
EP0913393B1 (de) 2003-02-12
KR19990037220A (ko) 1999-05-25
DE69811312D1 (de) 2003-03-20

Similar Documents

Publication Publication Date Title
DE69833464D1 (de) Pharmazeutische Zusammensetzung, enthaltend 2,3-Diaryl-PyrazoloÄ1,5-bÜPyridazin Derivate
DE69823858D1 (de) Amidderivate oder deren salze
EE9900359A (et) Diasendatud bitsüklilised heterotsüklid, nende valmistamine ja kasutamine ravimitena
DE69535171D1 (de) Poly-perfluoroalkylsubstituierte Alkohole und Säuren, und deren Derivate
TR199501209A2 (tr) Urea türevleri
NO20011216L (no) Azetidinderivater, deres fremstilling og medikamenter inneholdende forbindelsene
EE200000468A (et) Ühendid, nende kasutamine ja farmatseutiline kompositsioon
DE69622148T2 (de) Chinazozin derivate und deren verwendung
DE69606028D1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzung
DK0783302T3 (da) Lægemidler
CY2013003I1 (el) Φωσφονοκεφεμικα παραγωγα, διαδικασια για την παρασκευη τους, και χρηση αυτων
IS5353A (is) Asýl-píperasínil-pýrimídínafleiður, framleiðsla og notkun þeirra sem lyfja
NO985368D0 (no) Substituerte imidazolidinderivater, deres fremstilling, deres anvendelse og farmas°ytiske preparater inneholdende forbindelsene
DE59905572D1 (de) Substituierte 4-amino-2-aryl-pyrimidine, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
NO308287B1 (no) Substituerte 4-fenyl-6-amino-nikotinsyrederivater, legemidler inneholdende disse samt deres anvendelse
ATE449786T1 (de) Imidazolidinderivate, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
DE69524043D1 (de) Carbodiimide Derivate
ID27150A (id) Sediaan levotiroksin bahan farmasi
EE04398B1 (et) Asendatud 1,2,3,4,5,6-heksahüdro-2,6-metano-3-bensasotsiin-10-oolid, nende valmistamise meetod ja kasutamine ravimitena
DE69811312T2 (de) Arylacetamid Derivate, deren Salze und sie enthaltende Pharmazeutika
TR199501553A2 (tr) Sefem bilesimleri ve bunlarin farmasötik olarak kullanilmasi.
NO308213B1 (no) Substituerte indanylidinacetylguanidiner, deres anvendelse og medikamenter inneholdende forbindelsene
NO20003962L (no) Farmasøytiske preparater
DE69812260T2 (de) Chromenderivate und deren Salze und diese enthaltende pharmazeutische Zubereitungen
NO983918L (no) Nye ureaderivater

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee